Colef Robert, Mescallado Leslie, Kiran Nfn, Wrzolek Monika, Khan Shahbaz
Pathology and Laboratory Medicine, Northwell Health, New York City, USA.
Pathology and Laboratory Medicine, Staten Island University Hospital, New York City, USA.
Cureus. 2023 Nov 23;15(11):e49295. doi: 10.7759/cureus.49295. eCollection 2023 Nov.
Collecting duct carcinoma (CDC) is an aggressive renal malignancy with limited diagnostic and therapeutic consensus. We report a case of a 69-year-old male with CDC and extensive coagulative necrosis who presented with lower extremity swelling, abdominal distention, and an enlarged left kidney causing grade IV hydronephrosis. Initial treatment with a left percutaneous nephrostomy was followed by clinical deterioration and a diagnosis of emphysematous pyelonephritis. Pathological examination of drainage material revealed extensive coagulative necrosis and was suggestive of a necrotic neoplasm. Subsequent left nephrectomy confirmed CDC with high-grade features, stromal desmoplasia, and extensive coagulative necrosis. Immunohistochemistry studies supported the diagnosis. This study highlights the diagnostic complexity of CDC and emphasizes the need for accurate reporting of atypical presentations. CDC remains a formidable clinical entity with limited treatment options and poor outcomes. Further research is essential to enhance our understanding and management of this rare and aggressive renal malignancy.
集合管癌(CDC)是一种侵袭性肾恶性肿瘤,诊断和治疗共识有限。我们报告一例69岁男性患有CDC并伴有广泛凝固性坏死,表现为下肢肿胀、腹胀以及左肾增大导致IV级肾积水。最初采用左肾经皮肾造瘘术治疗,随后病情恶化,诊断为气肿性肾盂肾炎。引流物的病理检查显示广泛凝固性坏死,提示为坏死性肿瘤。随后的左肾切除术证实为具有高级别特征、间质促纤维增生和广泛凝固性坏死的CDC。免疫组织化学研究支持该诊断。本研究突出了CDC诊断的复杂性,并强调了准确报告非典型表现的必要性。CDC仍然是一个严峻的临床实体,治疗选择有限且预后不良。进一步的研究对于增进我们对这种罕见且侵袭性肾恶性肿瘤的理解和管理至关重要。